Adaptive Immunity Suppresses Formation and Progression of Diethylnitrosamine-Induced Liver Cancer

Gut - United Kingdom
doi 10.1136/gutjnl-2011-301116
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57bl/KsJ-+Leprdb/+Leprdb Mice

PLoS ONE
Multidisciplinary
2015English

MST1 Suppresses Pancreatic Cancer Progression via ROS Induced Pyroptosis

Molecular Cancer Research
Cancer ResearchOncologyMolecular Biology
2019English

Erratum: Inflammation-Induced IgA+ Cells Dismantle Anti-Liver Cancer Immunity

Nature
Multidisciplinary
2017English

Role of Adaptive Immunity in Alcoholic Liver Disease

International Journal of Hepatology
Hepatology
2012English

CsBAFF, a Teleost B Cell Activating Factor, Promotes Pathogen-Induced Innate Immunity and Vaccine-Induced Adaptive Immunity

PLoS ONE
Multidisciplinary
2015English

BAP1 Suppresses Lung Cancer Progression and Is Inhibited by miR-31

Oncotarget
Oncology
2016English

Effect of Diethylnitrosamine on Monoamine Oxidase in Rat Liver.

The Japanese Journal of Pharmacology
1989English

SPOP Suppresses Pancreatic Cancer Progression by Promoting the Degradation of NANOG

Cell Death and Disease
Molecular NeuroscienceImmunologyCell BiologyCancer ResearchCellularMedicine
2019English

The Role of microRNAs in Liver Cancer Progression

British Journal of Cancer
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy